Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University of ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
June 17, 2019 โ Initial results from the AVIATOR 2 international registry were presented as late-breaking clinical ...
June 14, 2019 โ Quantum Genomics announced the enrollment of the first patient in its QUORUM Phase IIb study of its lead ...
June 12, 2019 โ Boston Scientific Corp. has initiated the OPTION trial to compare safety and effectiveness of the next ...
May 29, 2019 โ Amarin Corp. plc announced that its supplemental new drug application (sNDA) for Vascepa (icosapent ethyl ...
May 17, 2019 โ The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection, for ...
May 6, 2019 โ The U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis ...
April 30, 2019 โ PhaseBio Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has granted ...
This video offers an overview of the Watchman left atrial appendage (LAA) occluder system, including information of its ...
April 24, 2019 โ New research from the University of Illinois at Chicago shows that when pharmacies close, people stop ...
April 19, 2019 โ Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that the recently ...
April 18, 2019 โ A recent study found patients with atherosclerotic cardiovascular disease cut their risk of a second ...
April 16, 2019 โ HonorHealth Research Institute announced the first patients have been enrolled in the SynIVUS-DAPT ...
April 15, 2019 โ Despite national guidelines indicating statins can lower risk of heart attack and stroke, many patients ...
March 29, 2019 โ The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...